Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4- phenylpyridinium-induced toxicity

Free Radical Biology and Medicine

Volumn 24, Issue 5, 1998, Pages 705-713

  Tsai, May J ^a   Lee, Eminy H Y ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cytoprotection; Energy metabolism; Free radicals; Rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CATALASE; CYCLIC GMP; DIMETHYL SULFOXIDE; FERROCYANIDE; FREE RADICAL; GLUTATHIONE; LACTIC ACID; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; N ACETYLPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; ROTENONE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENERGY METABOLISM; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIOXIDANTS; ASTROCYTES; CELLS, CULTURED; FREE RADICALS; MOLSIDOMINE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITROPRUSSIDE; PENICILLAMINE; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE;

ANIMALIA;

EID: 0032521385     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00329-8     Document Type: Article

References (71)

1. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. A primate model of parkinsonism Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine . Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
2. Heikkila R. E., Hess A., Duvoisin R. C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
3. Chiba K., Trevor A., Castagnoli N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:1984;574-578.
4. +. Neurosci. Lett. 75:1987;323-328.
5. Marini A. M., Lipsky R. H., Schwartz J. P., Kopin I. J. Accumulation of MPTP in cultured cerebellar astrocytes. J. Neurochem. 58:1992;1250-1258.
6. Tsai M. J., Lee E. H. Y. Differences in the disposition and toxicity of 1-methyl-4-phenyl pyridinium in cultured rat and mouse astrocytes. Glia. 12:1994;329-335.
7. + species in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 262:1992;225-230.
8. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H. Parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity . Proc. Natl. Acad. Sci. USA. 82:1985;2173-2177.
9. +) involves binding at the same site as the respiratory inhibitor, rotenone. Biochem. Biophys. Res. Commun. 169:1990;123-128.
10. Adams J. D., Odunze I. N. Oxygen free radicals and Parkinson's disease. Free Radic. Biol. Med. 10:1991;161-169.
11. + on isolated rat brain mitochondria Evidence for the primary involvement of energy depletion . J. Neurochem. 63:1994;640-648.
12. + . Free Radic. Biol. Med. 13:1992;581-583.
13. Poirier J., Barbeau A. A catalyst function for MPTP in superoxide formation. Biochem. Biophys. Res. Commun. 131:1985;1284-1289.
14. + Reductive activation by NADPH cytochrome P-450 reductase . Biochem. Biophys. Res. Commun. 135:1986;583-588.
15. Carboni S., Melis F., Pani L., Hadjiconstantinou M., Rossetti Z. L. The non-competitive NMDA receptor and antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum by 1-methyl-4-phenylpyridinium. Neurosci. Lett. 117:1990;129-133.
16. +). Biochem. Biophys. Res. Commun. 181:1991;1442-1448.
17. Dawson T. M., Dawson V. L., Synder S. H. A novel neuronal messenger molecule in brain The free radical, nitric oxide . Ann. Neurol. 32:1992;297-311.
18. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., Dawson T. M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
19. +-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. Neuroreport. 5:1994;2598-2600.
20. Rauhala P., Mohanakumar K. P., Sziraki I., Lin A. M. Y., Chiueh C. C. S-nitrosothiols and nitric oxide but not sodium nitroprusside protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse. 23:1996;58-60.
21. Rubanyi G. M., Ho E. H., Cantor E. H., Lumma W. C., Botelho L. H. Cytoprotective function of nitric oxide Inactivation of superoxide radicals produced by human leukocytes . Biochem. Biophys. Res. Commun. 181:1991;1392-1397.
22. Wink D. A., Hanbauer I., Krishna M. C., DeGraff W., Gamson J., Mitchell J. B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA. 90:1993;9813-9817.
23. Wink D. A., Cook J. A., Krishna M. C., Hanbauer I., DeGraff W., Gamson J., Mitchell J. B. Nitric oxide protects against alkyl peroxide-mediated cytotoxicity Further insights into the role of nitric oxide plays in oxidative stress . Arch. Biochem. Biophys. 319:1995;402-407.
24. Wink D. A., Cook J. A., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M. C., Mitchell J. B. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity A direct correlation between nitric oxide formation and protection . Arch. Biochem. Biophys. 331:1996;241-248.
25. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
26. 10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp. Neurol. 132:1995;279-283.
27. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E., Beal M. F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
28. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., Snyder S. H. Mechanism of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
29. Bockelmann R., Wolf G., Ransmayr G., Riederer P. NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen. J. Neural Transm. 7:1994;115-121.
30. Mufson E. J., Brandabur M. M. Sparing of NADPH-diaphorase striatal neurons in Parkinson's and Alzheimer's diseases. Neuroreport. 5:1994;705-708.
31. Markar T. K., Nedergaard M., Preuss A., Gelbard A. S., Perumal A. S., Cooper A. J. L. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurones Evidence that astrocytes play an important role in antioxidative stress in the brain . J. Neurochem. 62:1994;45-53.
32. Sagara J., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61:1993;1672-1676.
33. Bolanos J. P., Heales S. J. R., Land J. M., Clark J. B. Effect of peroxynitrite on the mitochondrial respiratory chain Differential susceptibility of neurons and astrocytes in primary cultures . J. Neurochem. 64:1995;1965-1972.
34. Adams J. D. Jr, Kalivas P. W., Miller C. A. The acute histopathology of MPTP in the mouse CNS. Brain Res. Bull. 23:1989;1-17.
35. +). Neurosci. Lett. 141:1992;203-207.
36. Di Monte D. A., Wu E. Y., Delanney L. E., Irwin I., Langston J. W. Toxicity of MPTP in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 261:1992;44-49.
37. Tsai M. J., Lee E. H. Y. Characterization of L-DOPA transport in cultured rat and mouse astrocytes. J. Neurosci. Res. 43:1996;490-495.
38. Juurlink B. H. J., Hertz L. Establishment of highly enriched type-2 astrocyte cultures and quantitative determination of intense glutamine synthetase activity in these cells. J. Neurosci. Res. 30:1991;531-539.
39. Noll, F. L. Lactate. In: Bergmeyer, H. U.; Bergmeyer, J.; Grass1, M.; eds. Methods of enzymatic analysis (Vol. 6). FL: Weinhei; 1984:582-589.
40. Koh J. Y., Choi D. W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Meth. 20:1987;83-90.
41. Berridge M. V., Tan A. S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) Subcellular localization, substrate dependence and involvement of mitochondrial electron transport in MTT reduction . Arch. Biochem. Biophys. 303:1993;474-482.
42. Mossman T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J. Immunol. Meth. 65:1983;55-63.
43. Esterbauer H., Cheeseman K. H. Determination of aldehydic lipid peroxidation products Malonaldehyde and 4-hydroxynonenal . Meth. Enzymol. 186:1990;407-421.
44. Hung H-C., Lee E. H. Y. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic. Biol. Med. 24:1998;76-84.
45. Lemasters J. J., Hackenbrock C. R. Firefly luciferase assay for ATP production by mitochondria. Meth. Enzymol. 56:1979;530-544.
46. Bradford M. M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
47. Jeffery E. H., Arndt K., Haschek W. M. Mechanism of inhibition of hepatic bioactivation of paracetamol by dimethyl sulfoxide. Drug Metabol. Drug Interact. 6:1988;413-424.
48. Blaustein A., Deneke S. M., Stolz R. I., Baxter D., Healey N., Fanburg B. L. Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation. 80:1989;1449-1457.
49. Michael L. H., Zhang Z., Hartley C. J., Bolli R., Taylor A. A., Entman M. L. Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion. Circ. Res. 66:1990;1040-1044.
50. +-induced cell injury in the striatum of rats. Br. J. Pharmacol. 111:1994;837-842.
51. + neurotoxicity by N-methyl-D-aspartate antagonists. Brain Res. 586:1992;203-207.
52. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349:1991;414-418.
53. Ignarro L. J., Lipton H., Edwards J. C., Baricos W. H., Hyman A. L., Kadowitz P. J., Gruetter C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide Evidence for the involvement of S-nitrosothiols as active intermediates . J. Pharmacol. Exp. Ther. 218:1981;739-749.
54. Kanner J., Harel S., Granit R. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289:1991;130-136.
55. Rubanyi G. M. Endothelium-derived relaxing and contracting factors. J. Cell. Biochem. 46:1991;27-36.
56. + induced oxygen radical formation with mitochondrial enzymes. Free Radic. Biol. Med. 15:1993;181-186.
57. + neurotoxicity against rat dopaminergic neurons in culture. Neurosci. Lett. 193:1995;53-56.
58. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Stephen B., Kirk M., Freeman B. A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem. 269:1994;26066-26075.
59. Miles A. M., Bohle D. S., Glassbrenner P. A., Hansert B., Wink D. A., Grisham M. B. Modulation of superoxide-dependent oxidation and hydroxylation reaction by nitric oxide. J. Biol. Chem. 271:1996;40-47.
60. + Evidence for free radical involvement . J. Neurochem. 58:1992;786-789.
61. + Evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase . Free Radic. Biol. Med. 15:1993;169-179.
62. Kiedrowski L., Manev H., Costa E., Wroblewski J. T. Inhibition of glutamate-induced cell death by sodium nitroprusside is not mediated by nitric oxide. Neuropharmacology. 30:1991;1241-1243.
63. Schapira A. H. V., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B., Marsden C. D. Anatomic and disease specificity of NADH-CoQ reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55:1990;2142-2145.
64. Ramsay R. R., Salach J. I., Dadgar J., Singer T. P. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem. Biophys. Res. Commun. 135:1986;269-275.
65. Crane F. L., Sun I. L., Clark M. G., Grebing C., Low H. Transplasma-membrane redox systems in growth and development. Biochim. Biophys. Acta. 811:1985;233-264.
66. Mersel M., Malviya A. N., Hindelang C., Mandel P. Plasma membrane isolated from astrocytes in primary cultures. Its acceptor oxidoreductase properties. Biochim. Biophys. Acta. 778:1984;144-154.
67. Larm J. A., Vaillant F., Linnane A. W., Lawen A. Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa Rho cells. J. Biol. Chem. 269:1994;30097-30100.
68. Ramsay R. R., Singer T. P. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. J. Biol. Chem. 261:1986;7585-7587.
69. + and its analogs with rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56:1991;1184-1190.
70. + and of respiratory chain inhibitor piericidin A are the same. Biochem. J. 273:1991;481-484.
71. Glinka Y., Tipton K. F., Youdim M. B. H. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66:1996;2004-2010.